Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP

Eyad Elkord, May Abd Al Samid, Belal Chaudhary

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Regulatory T cells (Tregs) are key players of immune regulation/dysregulation both in physiological and pathophysiological settings. Despite significant advances in understanding Treg function, there is still a pressing need to define reliable and specific markers that can distinguish different Treg subpopulations. Herein we show for the first time that markers of activated Tregs [latency associated peptide (LAP) and glycoprotein A repetitions predominant (GARP, or LRRC32)] are expressed on CD4+FoxP3- T cells expressing Helios (FoxP3-Helios+) in the steady state. Following TCR activation, GARP/LAP are up-regulated on CD4+Helios+ T cells regardless of FoxP3 expression (FoxP3+/-Helios+). We show that CD4+GARP+/-LAP+ Tregs make IL-10 immunosuppressive cytokine but not IFN-γ effector cytokine. Further characterization of FoxP3/Helios subpopulations showed that FoxP3+Helios+ Tregs proliferate in vitro significantly less than FoxP3+Helios- Tregs upon TCR stimulation. Unlike FoxP3+Helios- Tregs, FoxP3+Helios+ Tregs secrete IL-10 but not IFN-γ or IL-2, confirming they are bona fide Tregs with immunosuppressive characteristics. Taken together, Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP, and FoxP3+Helios+ Tregs have more suppressive characteristics, compared with FoxP3+Helios- Tregs. Our work implies that therapeutic modalities for treating autoimmune and inflammatory diseases, allergies and graft rejection should be designed to induce and/or expand FoxP3+Helios+ Tregs, while therapies against cancers or infectious diseases should avoid such expansion/induction.

Original languageEnglish
Pages (from-to)20026-20036
Number of pages11
JournalOncotarget
Volume6
Issue number24
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Peptides
Immunosuppressive Agents
Interleukin-10
Cytokines
T-Lymphocytes
Graft Rejection
Regulatory T-Lymphocytes
Autoimmune Diseases
Interleukin-2
Communicable Diseases
Glycoproteins
Hypersensitivity
Therapeutics
Neoplasms
In Vitro Techniques

Keywords

  • FoxP3
  • GARP/LAP
  • Helios
  • Immune response
  • Immunity
  • Immunology and microbiology section
  • Regulatory T cells

ASJC Scopus subject areas

  • Oncology

Cite this

Elkord, E., Al Samid, M. A., & Chaudhary, B. (2015). Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP. Oncotarget, 6(24), 20026-20036.

Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP. / Elkord, Eyad; Al Samid, May Abd; Chaudhary, Belal.

In: Oncotarget, Vol. 6, No. 24, 2015, p. 20026-20036.

Research output: Contribution to journalArticle

Elkord, E, Al Samid, MA & Chaudhary, B 2015, 'Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP', Oncotarget, vol. 6, no. 24, pp. 20026-20036.
Elkord, Eyad ; Al Samid, May Abd ; Chaudhary, Belal. / Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP. In: Oncotarget. 2015 ; Vol. 6, No. 24. pp. 20026-20036.
@article{90334796158645e381435067b3b7da88,
title = "Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP",
abstract = "Regulatory T cells (Tregs) are key players of immune regulation/dysregulation both in physiological and pathophysiological settings. Despite significant advances in understanding Treg function, there is still a pressing need to define reliable and specific markers that can distinguish different Treg subpopulations. Herein we show for the first time that markers of activated Tregs [latency associated peptide (LAP) and glycoprotein A repetitions predominant (GARP, or LRRC32)] are expressed on CD4+FoxP3- T cells expressing Helios (FoxP3-Helios+) in the steady state. Following TCR activation, GARP/LAP are up-regulated on CD4+Helios+ T cells regardless of FoxP3 expression (FoxP3+/-Helios+). We show that CD4+GARP+/-LAP+ Tregs make IL-10 immunosuppressive cytokine but not IFN-γ effector cytokine. Further characterization of FoxP3/Helios subpopulations showed that FoxP3+Helios+ Tregs proliferate in vitro significantly less than FoxP3+Helios- Tregs upon TCR stimulation. Unlike FoxP3+Helios- Tregs, FoxP3+Helios+ Tregs secrete IL-10 but not IFN-γ or IL-2, confirming they are bona fide Tregs with immunosuppressive characteristics. Taken together, Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP, and FoxP3+Helios+ Tregs have more suppressive characteristics, compared with FoxP3+Helios- Tregs. Our work implies that therapeutic modalities for treating autoimmune and inflammatory diseases, allergies and graft rejection should be designed to induce and/or expand FoxP3+Helios+ Tregs, while therapies against cancers or infectious diseases should avoid such expansion/induction.",
keywords = "FoxP3, GARP/LAP, Helios, Immune response, Immunity, Immunology and microbiology section, Regulatory T cells",
author = "Eyad Elkord and {Al Samid}, {May Abd} and Belal Chaudhary",
year = "2015",
language = "English",
volume = "6",
pages = "20026--20036",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "24",

}

TY - JOUR

T1 - Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP

AU - Elkord, Eyad

AU - Al Samid, May Abd

AU - Chaudhary, Belal

PY - 2015

Y1 - 2015

N2 - Regulatory T cells (Tregs) are key players of immune regulation/dysregulation both in physiological and pathophysiological settings. Despite significant advances in understanding Treg function, there is still a pressing need to define reliable and specific markers that can distinguish different Treg subpopulations. Herein we show for the first time that markers of activated Tregs [latency associated peptide (LAP) and glycoprotein A repetitions predominant (GARP, or LRRC32)] are expressed on CD4+FoxP3- T cells expressing Helios (FoxP3-Helios+) in the steady state. Following TCR activation, GARP/LAP are up-regulated on CD4+Helios+ T cells regardless of FoxP3 expression (FoxP3+/-Helios+). We show that CD4+GARP+/-LAP+ Tregs make IL-10 immunosuppressive cytokine but not IFN-γ effector cytokine. Further characterization of FoxP3/Helios subpopulations showed that FoxP3+Helios+ Tregs proliferate in vitro significantly less than FoxP3+Helios- Tregs upon TCR stimulation. Unlike FoxP3+Helios- Tregs, FoxP3+Helios+ Tregs secrete IL-10 but not IFN-γ or IL-2, confirming they are bona fide Tregs with immunosuppressive characteristics. Taken together, Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP, and FoxP3+Helios+ Tregs have more suppressive characteristics, compared with FoxP3+Helios- Tregs. Our work implies that therapeutic modalities for treating autoimmune and inflammatory diseases, allergies and graft rejection should be designed to induce and/or expand FoxP3+Helios+ Tregs, while therapies against cancers or infectious diseases should avoid such expansion/induction.

AB - Regulatory T cells (Tregs) are key players of immune regulation/dysregulation both in physiological and pathophysiological settings. Despite significant advances in understanding Treg function, there is still a pressing need to define reliable and specific markers that can distinguish different Treg subpopulations. Herein we show for the first time that markers of activated Tregs [latency associated peptide (LAP) and glycoprotein A repetitions predominant (GARP, or LRRC32)] are expressed on CD4+FoxP3- T cells expressing Helios (FoxP3-Helios+) in the steady state. Following TCR activation, GARP/LAP are up-regulated on CD4+Helios+ T cells regardless of FoxP3 expression (FoxP3+/-Helios+). We show that CD4+GARP+/-LAP+ Tregs make IL-10 immunosuppressive cytokine but not IFN-γ effector cytokine. Further characterization of FoxP3/Helios subpopulations showed that FoxP3+Helios+ Tregs proliferate in vitro significantly less than FoxP3+Helios- Tregs upon TCR stimulation. Unlike FoxP3+Helios- Tregs, FoxP3+Helios+ Tregs secrete IL-10 but not IFN-γ or IL-2, confirming they are bona fide Tregs with immunosuppressive characteristics. Taken together, Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP, and FoxP3+Helios+ Tregs have more suppressive characteristics, compared with FoxP3+Helios- Tregs. Our work implies that therapeutic modalities for treating autoimmune and inflammatory diseases, allergies and graft rejection should be designed to induce and/or expand FoxP3+Helios+ Tregs, while therapies against cancers or infectious diseases should avoid such expansion/induction.

KW - FoxP3

KW - GARP/LAP

KW - Helios

KW - Immune response

KW - Immunity

KW - Immunology and microbiology section

KW - Regulatory T cells

UR - http://www.scopus.com/inward/record.url?scp=84940171692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940171692&partnerID=8YFLogxK

M3 - Article

C2 - 26343373

VL - 6

SP - 20026

EP - 20036

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 24

ER -